A Bold Vision and a Brand Identity for the Planning Profession

R. W. Firestone's Cityscape Pink is a bold image capturing the essence of a city. In this Longer View essay, Bruce McClendon argues that the profession of planning needs a similarly bold vision and compelling brand identity in order to claim its proper place among many competitors offering similar services. He aims to distinguish the planning profession in the eyes of the public and the minds of planners themselves. Three commenters respond with different perspectives on the status of the profession and how best to improve it.

Firestone is a psychotherapist with a PhD in clinical psychology from the University of Denver and the author of nine books. He grew up in the New York City area and opened his private practice in Los Angeles, treating patients suffering from schizophrenia. With a group of friends he has sailed to many parts of the world, and both his practice and his travels figure into the subjects of his artwork.

Planning has become a generic product in a confusing, overcrowded, and highly competitive marketplace. The public does not know what planning is or how to differentiate among planning specialists. Relying on a bold back-to-the-future approach, I argue that it is the production, administration, and implementation of comprehensive plans that once was and still is the profession's unique and distinctive technical competency and core mission. By using branding techniques to define, link, and reconnect planners with comprehensive planning, it will be possible to tell the planning story in a way that communicates the emotional benefits and value of the profession and strengthens the public's respect and appreciation for planners.     

Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma

Oral cancer often presents with aggressive behavior and a high risk of recurrence and metastasis. For oral squamous cell carcinoma (OSCC), which is the most frequent histological subtype, therapy strategies include surgery, radiation therapy, chemotherapy, immune checkpoint inhibitors, and EGFR inhibitors. Recently, a Trop-2 antibody-drug conjugate (ADC) has been approved in the United States of America for the treatment of advanced triple-negative breast cancer. However, this ADC has also been tested in other solid tumors including head & neck squamous cell carcinoma. The prognostic impact of Trop-2 has already been reported for several cancers. We studied the prognostic influence of Trop-2 protein expression on OSCC patients’ survival. The cohort comprised n = 229 OSCC patients with available archived tumor tissue and corresponding non-neoplastic oral mucosa tissue. Using immunohistochemistry, we investigated Trop-2 expression in both the central and peripheral regions of each tumor and in corresponding non-neoplastic oral mucosa. In patients suffering from OSCC with combined high central and low peripheral Trop-2 expression, five-year overall survival (OS) was 41.2%, whereas 55.6% of OSCC patients who presented lower central and/or higher peripheral tumoral Trop-2 expression were alive after five years (p = 0.075). In multivariate Cox regression, the expression pattern of high central tumoral and lower peripheral Trop-2 expression was significantly correlated with impaired OS (HR = 1.802, 95%-CI: 1.134–2.864; p = 0.013) and recurrence-free survival (RFS) (HR = 1.633, 95%-CI: 1.042–2.560; p = 0.033), respectively, when adjusting for co-variables. Hence, Trop-2 may serve as an independent prognostic biomarker in OSCC. In subsequent studies, the pathophysiological meaning of downregulated Trop-2 expression in the OSCC periphery has to be analyzed.     

Fatigue,Magnetic and Mechanical Hysteresis

Abstract: The objective of this research is to explore correlations between piezomagnetic signals of initially unmagnetised ferromagnetic steel samples of AISI 1018 steel with progressive changes that take place during the fatigue process. A series of strain‐controlled fatigue tests were carried out to quantitatively study the piezomagnetic fields surrounding steel specimens by measuring magnetic field variations in the milligauss range resulting from the cyclic application of stress. It was observed that the piezomagnetic hysteresis traces change systematically with the progression of fatigue. The piezomagnetic hysteresis loop areas, when plotted as a function of the number of loading cycles, demonstrate the three principal stages of fatigue: initial accommodation, accretion of damage and terminal failure. The results derived from the piezomagnetic hysteresis traces are consistent with those obtained from mechanical hysteresis studies. However, when approaching failure, the piezomagnetic traces show more conspicuous changes than the corresponding mechanical stress–strain curves. It was also observed that the piezomagnetic field surrounding a specimen subjected to cyclic loading behaves approximately like that of a bar magnet. This study has demonstrated that the piezomagnetic effects can be exploited to evaluate the progress of fatigue in ferromagnetic steels.     

TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer

Recent studies have suggested that different mutation types within the core domain of the tumour suppressor protein p53, i.e. DNA contact mutations and structural mutations, confer different biological properties. We have analysed in 86 head and neck squamous cell carcinomas (HNSCC), whether these p53 mutation types have a differential clinical impact. Thirty-seven missense mutations were identified. Thirteen of these (36%) were DNA contact mutations, occurring in the L3 loop, in the H2 loop sheet helix motif, in the S10 beta strand and in Zinc binding residues. Microsatellite marker analysis revealed a selective association between these mutations and the loss of wild-type alleles (100% LOH vs 50% LOH in tumours with structural mutations; P=0.0034, Fisher's exact, 2-tailed). In comparison to structural mutations or to the absence of mutations in the core domain, DNA contact mutations were associated with higher tumour stages (84.6% vs 62%), a higher incidence of lymph node metastasis (91.7% vs 56%; P=0.014, Fisher's exact, 2-tailed), a shortened recurrence-free survival (8.1 months vs 23.7 months, P=0.047, log rank test) and overall survival (11 months vs 29.2 months; P=0.003, log rank test). The latter was also the case when only stage IV tumours were analysed (P=0.0055, log rank test). These data indicate that in HNSCC, TP53 DNA contact mutations confer a strong selection pressure to eliminate wild-type alleles, and that they result in an accelerated tumour progression and reduced therapeutic responsiveness.     

The effect of minimum luminal nutrition on mucosal cellularity and immunity of the gut

Many catabolic patients can only consume small volumes of enteral nutrients. The aim of this study was to evaluate markers of cellularity and immunity in the small intestine of rats randomized to receive 6 days of parenteral nutrition, 25% enteral and 75% parenteral nutrition (i.e. minimum luminal nutrition) or enteral nutrition. The same glutamine-enriched solution was used for both parenteral and enteral nutrition. Enteral nutrition was associated with the least amount of jejunal atrophy (P<0.01), with the results from the minimum luminal nutrition group approximating those of the parenteral nutrition group. Parenteral nutrition was associated with the greatest number of CD2+ cells (P< 0.05) and the lowest CD4/CD8 cell ratio (P< 0.01) in the jejunal mucosa. In essence, we failed to demonstrate that there are any appreciable benefits associated with the enteral consumption of 25% of a nutrient load.     

Human CD22-Transgenic,Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments

Targeted immunotherapies have greatly changed treatment of patients with B cell malignancies. To further enhance immunotherapies, research increasingly focuses on the tumor microenvironment (TME), which differs considerably by organ site. However, immunocompetent mouse models of disease to study immunotherapies targeting human molecules within organ-specific TME are surprisingly rare. We developed a myc-driven, primary murine lymphoma model expressing a human-mouse chimeric CD22 (h/mCD22). Stable engraftment of three distinct h/mCD22⁺ lymphoma was established after subcutaneous and systemic injection. However, only systemic lymphoma showed immune infiltration that reflected human disease. In this model, myeloid cells supported lymphoma growth and showed a phenotype of myeloid-derived suppressor cells. The human CD22-targeted immunotoxin Moxetumomab was highly active against h/mCD22⁺ lymphoma and similarly reduced infiltration of bone marrow and spleen of all three models up to 90-fold while efficacy against lymphoma in lymph nodes varied substantially, highlighting relevance of organ-specific TME. As in human aggressive lymphoma, anti-PD-L1 as monotherapy was not efficient. However, anti-PD-L1 enhanced efficacy of Moxetumomab suggesting potential for future clinical application. The novel model system of h/mCD22⁺ lymphoma provides a unique platform to test targeted immunotherapies and may be amenable for other human B cell targets such as CD19 and CD20.     

Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting

In intermediate risk hormone receptor (HR) positive, HER2 negative breast cancer (BC), the decision regarding adjuvant chemotherapy might be facilitated by multigene expression tests. In all, 142 intermediate risk BCs were investigated using the PAM50-based multigene expression test Prosigna® in a prospective multicentric study. In 119/142 cases, Prosigna® molecular subtyping was compared with local and two central (C1 and C6) molecular-like subtypes relying on both immunohistochemistry (IHC; HRs, HER2, Ki-67) and IHC + tumor grade (IHC+G) subtyping. According to local IHC, 35.4% were Luminal A-like and 64.6% Luminal B-like subtypes (local IHC+G subtype: 31.9% Luminal A-like; 68.1% Luminal B-like). In contrast to local and C1 subtyping, C6 classified >2/3 of cases as Luminal A-like. Pairwise agreement between Prosigna® subtyping and molecular-like subtypes was fair to moderate depending on molecular-like subtyping method and center. The best agreement was observed between Prosigna® (53.8% Luminal A; 44.5% Luminal B) and C1 surrogate subtyping (Cohen’s kappa = 0.455). Adjuvant chemotherapy was suggested to 44.2% and 88.6% of Prosigna® Luminal A and Luminal B cases, respectively. Out of all Luminal A-like cases (locally IHC/IHC+G subtyping), adjuvant chemotherapy was recommended if Prosigna® testing classified as Prosigna® Luminal A at high / intermediate risk or upgraded to Prosigna® Luminal B.     

Age and forgetfulness: Managing perceivers' impressions of targets' capability.

Two experiments investigated the effect of positive endorsement on perceivers' impressions of young and old female targets. In Experiment 1, 160 young adult perceivers listened to a tape of a young or old forgetful target being interviewed for a volunteer job. They read a nonelaborative or elaborative reference letter for the target either before or after listening to the tape. Perceivers who read the elaborative letter after listening to the tape rated themselves as more likely to assign tasks to both young and old targets and had a higher general capability opinion of old targets. In Experiment 2, 84 older adult perceivers read an elaborative letter and listened to one of the same taped interviews. Reading the letter after the tape resulted in higher task ratings than reading it before the tape, but letter order had no effect on general capability ratings. Results are discussed in terms of impression management. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Ironic processes in the mental control of mood and mood-related thought.

Investigated the mental control of mood and mood-related thought. In Exp 1, Ss reminiscing about a happy or sad event were asked to make their mood positive, were given no instructions, or were asked to make their mood negative. Ss attempting mood control without an imposed cognitive load were successful, whereas those who attempted control while rehearsing a 9-digit number not only failed to control their moods, but also showed self-reported mood change opposite the mood they intended to create. In Exp 2, Ss attempting to control mood-related thoughts under cognitive load showed increased accessibility of those thoughts contrary to the direction of intended control in a Stroop-type color-naming task. (PsycINFO Database Record (c) 2010 APA, all rights reserved)